DiRx, an online pharmacy platform that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance, has raised USD5.75 million in Series A funding. Additional funding interest is under advanced contract negotiations and will conclude in the coming weeks. Coinciding with the anniversary of its initial USD5
Spark Orthodontics, aa orthodontic group practice with 10 offices in Pennsylvania, and in which Rock Mountain Capital holds a significant minority investment, today announced the acquisition of Cumberland Pediatric Dentistry & Orthodontics of Tennessee. Financial terms of the deal have not been disclosed. Cumberland’s eight offices in the Nashville, TN
Ridgemont Equity Partners, a middle market private equity investor, has acquired Agape Care Group (Agape Care), a provider of hospice and palliative care in the South East USA, with a deep presence across South Carolina and Georgia. The Company offers full end-of-life care for members of its community both in
Buyout specialist Kester Capital (Kester), has invested in Rephine, a provider of Good Manufacturing/Clinical Practice (GMP/GCP) audits and regulatory consulting services to the pharmaceutical industry. The investment represents Kester’s fourth investment in the Life Sciences sector, and the fourth investment out of its latest fund, Kester Capital II, which closed
Global Healthcare Exchange (GHX) has acquired Chicago-based Explorer Surgical Corp, operator of a comprehensive digital and remote case support platform that connects suppliers with healthcare provider teams. By combining Explorer Surgical’s digital expertise in creating innovative procedure playbooks, tele-mentoring and performance tracking tools with GHX’s cloud-based supply chain network and
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India. The acquisition of Ideal Cures underscores the importance of India in the pharmaceutical sector by
Abalos Therapeutics has completed its Series A funding round bringing the total raised in this round to EUR43 million (USD50 million). The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from existing investors from the initial Series
Precisis, a medical technology company that develops methods to relieve epilepsy patients from their symptoms, has acquired additional funding of EUR20 million. The additional funding will be used to support ongoing clinical studies and to further advance EASEE(R), an implantable bioelectric brain stimulation system that explores novel approaches to treating
Permira funds have agreed to the sale of Lyophilization Services of New England (LSNE), a contract manufacturing organisation, to PCI Pharma Services (PCI), a pharmaceutical and biopharmaceutical global integrated solutions provider. Founded in 1997 and headquartered in Bedford, New Hampshire, LSNE is a market leader providing a wide range of
Bond Vet, a design-forward, tech-enabled brand of veterinary care clinics in New York, has secured a USD170 million investment from growth investor Warburg Pincus. The funding will be used to expand Bond Vet’s footprint and invest in equipment, training, culture and technology to further improve the clinical experience for veterinarians,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
